Treventis Scientific Founder Named 2009 Recipient of Prix Galien Canada Award for Alzheimer’s Disease
Read more here
News
BioAdvance Expands Team to Support Portfolio and Future Investments
Read more here
BioAdvance Funds Treventis to Advance Alzheimer’s Drug Discovery
Read more here
QR Taps Region’s Proven Experts
Read more here
BioAdvance Names Dr. Philip P. Gerbino Chair and Elects Dr. John M. Daly to Board of Directors
Read more here